ESMO 2023

Novel Discoveries in Oncology

Indivumed Therapeutics is a global oncology company, with a focus on bioinformatics and multi-omics-based oncology R&D. Utilizing the same high-quality multi-omics and clinical datasets all the way through, we use AI-assisted advanced analytics to drive biomarker discovery as well as novel target identification and validation for potential therapies.


Get a brief overview of our work and what we have in store for you at ESMO.

From Sample To Drug

Discover our Holistic Workflow step by step.


Join our Poster Presentation

Combining Cancer Patient Spatial Transcriptomics and bulk RNA-Seq data to drive insights into NSCLC

October 21, 2023, 12 – 1 pm, Hall 8 Poster Area

There is more to discover

Contacts and Appointments

Click this link to get in touch with our team

From Sample to Drug Deep Dive

Learn more about our holistic workflow

We Move Precision Oncology Forward

Visit our main website to get a complete picture of Indivumed Therapeutics